These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1247 related items for PubMed ID: 2147780

  • 21. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 22. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM, Boldry RC, Kuo S, Chase TN.
    Brain Res; 1992 May 29; 581(2):261-8. PubMed ID: 1356580
    [Abstract] [Full Text] [Related]

  • 23. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Robertson GS.
    Eur J Neurosci; 1996 Feb 29; 8(2):365-81. PubMed ID: 8714707
    [Abstract] [Full Text] [Related]

  • 24. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP.
    Brain Res; 1989 Oct 23; 500(1-2):119-30. PubMed ID: 2481560
    [Abstract] [Full Text] [Related]

  • 25. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
    Le Moine C, Svenningsson P, Fredholm BB, Bloch B.
    J Neurosci; 1997 Oct 15; 17(20):8038-48. PubMed ID: 9315922
    [Abstract] [Full Text] [Related]

  • 26. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM, Ye H, Pennypacker KR, Hudson PM, Hong JS.
    Brain Res Mol Brain Res; 1994 May 15; 23(3):191-203. PubMed ID: 7914658
    [Abstract] [Full Text] [Related]

  • 27. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
    Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G.
    Neuroscience; 1999 May 15; 88(4):1005-8. PubMed ID: 10336115
    [Abstract] [Full Text] [Related]

  • 28. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Synapse; 1990 May 15; 5(2):83-93. PubMed ID: 2309160
    [Abstract] [Full Text] [Related]

  • 29. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
    Frau L, Morelli M, Simola N.
    Exp Neurol; 2013 Sep 15; 247():663-72. PubMed ID: 23499830
    [Abstract] [Full Text] [Related]

  • 30. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P, Mercuri NB, Sancesario G, Bernardi G.
    Brain; 1993 Apr 15; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [Abstract] [Full Text] [Related]

  • 31. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA, Gerfen CR.
    Neuroscience; 1995 Jun 15; 66(4):903-13. PubMed ID: 7651617
    [Abstract] [Full Text] [Related]

  • 32. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF, Aloyo VJ, Weiss B.
    Neuroscience; 1993 Jun 15; 54(3):669-80. PubMed ID: 8101360
    [Abstract] [Full Text] [Related]

  • 33. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L.
    Synapse; 1990 Jun 15; 5(2):113-9. PubMed ID: 2137942
    [Abstract] [Full Text] [Related]

  • 34. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.
    Weiss B, Zhou LW, Zhang SP, Qin ZH.
    Neuroscience; 1993 Aug 15; 55(3):607-12. PubMed ID: 8413923
    [Abstract] [Full Text] [Related]

  • 35. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos.
    Robertson GS, Vincent SR, Fibiger HC.
    Brain Res; 1990 Jul 23; 523(2):288-90. PubMed ID: 2144781
    [Abstract] [Full Text] [Related]

  • 36. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 37. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 07; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 38. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
    Ruskin DN, Marshall JF.
    Brain Res; 1995 Dec 12; 703(1-2):156-64. PubMed ID: 8719628
    [Abstract] [Full Text] [Related]

  • 39. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX, Bergstrom DA, Ruskin DN, Walters JR.
    Synapse; 1998 Sep 12; 30(1):18-29. PubMed ID: 9704877
    [Abstract] [Full Text] [Related]

  • 40. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B, Frenois F, Zold CL, Chetrit J, Murer MG, Gonon F.
    Neurobiol Dis; 2009 Sep 12; 35(3):376-84. PubMed ID: 19501163
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 63.